Hui Xiong | Bio Materials | Best Researcher Award

Dr. Hui Xiong | Bio Materials | Best Researcher Award

Associate Professor | China Pharmaceutical University | China

Dr. Hui Xiong is an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University. Her work bridges pharmaceutics, tumor biology, and nanomedicine engineering to create advanced drug delivery systems that improve cancer treatment outcomes. SCI-indexed publications as first or corresponding author, her research contributions have been featured in high-impact journals such as ACS Nano, Nano Letters, Journal of Controlled Release, Small, and Advanced Healthcare Materials. She holds an H-index of 16, four national invention patents, and has secured multiple research grants from the National Natural Science Foundation of China and other prestigious programs. Dr. Xiong’s research emphasizes multifunctional nanocarriers, targeted therapy, tumor microenvironment modulation, and ferroptosis-inducing strategies, particularly for breast cancer. Her translational approach seeks to bridge laboratory innovation with clinical applications, offering new therapeutic paradigms in oncology. Through her leadership and contributions, she has established herself as a rising scholar in nanomedicine-driven pharmaceutics.

Professional Profile

Scopus

Education

Dr. Hui Xiong obtained her Ph.D. in Pharmaceutics from China Pharmaceutical University, one of the leading institutions for pharmaceutical sciences in China. During her doctoral studies, she specialized in advanced drug delivery systems, focusing on the design of multifunctional nanocarriers to overcome therapeutic limitations in cancer treatment. Her doctoral research introduced novel hydroxyapatite-based dual-targeted nanoparticles that enhanced the efficacy of chemotherapeutic drugs, laying the foundation for her later work on multifunctional nanoplatforms. Her training combined pharmaceutics, materials science, and tumor biology, allowing her to integrate multidisciplinary strategies for addressing challenges such as poor bioavailability, tumor heterogeneity, and drug resistance. Following her doctoral training, she expanded her expertise by engaging in postdoctoral projects supported by national and provincial research programs. This educational foundation not only provided her with strong theoretical and technical skills but also shaped her research trajectory toward translational nanomedicine and oncology-focused pharmaceutics.

Experience

Dr. Hui Xiong currently serves as an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University. She has established an independent research program focusing on cancer-targeted nanomedicine and innovative drug delivery platforms. Over the years, she has published extensively in top-tier journals, including ACS Nano, Nano Letters, and Journal of Controlled Release. She has successfully led multiple projects funded by the National Natural Science Foundation of China, China Postdoctoral Science Foundation, and Jiangsu Provincial Research Grants. Beyond publishing Dr. Xiong has also filed and secured four national invention patents, underscoring her commitment to both academic advancement and practical innovation. She is recognized for her work in creating rationally designed drug carriers that integrate features such as stimuli-responsiveness, tumor microenvironment modulation, and combination therapy strategies. Through her academic and research positions, Dr. Xiong has cultivated expertise that translates pharmaceutics research into clinically applicable cancer therapies.

Research Focus

Dr. Hui Xiong’s research is centered on the rational design and development of advanced nanomedicine platforms for cancer therapy. Her work integrates pharmaceutics, materials science, and tumor biology to address major limitations of traditional chemotherapy, including poor bioavailability, drug resistance, and systemic toxicity. She focuses on designing multifunctional and stimuli-responsive nanocarriers capable of precise targeting, controlled release, and tumor microenvironment remodeling. Key directions of her research include pH-activated antiangiogenic therapies, ferroptosis-inducing nanodrugs, vascular normalization strategies, and immune modulation approaches. Her translational research emphasizes applications in breast cancer and pancreatic cancer, where innovative nanoplatforms have demonstrated improved therapeutic indices and synergistic combination effects. Recent studies include self-assembled nano-activators for ferroptosis-immunotherapy, redox-regulated nanodrugs, and bioengineered nanospores targeting tumor-associated macrophages. Ultimately, her research goal is to transform laboratory discoveries into clinically relevant therapies that enhance the precision, safety, and efficacy of oncology treatments, paving the way for next-generation pharmaceutics innovations.

Awards and Honors

Throughout her academic career, Dr. Hui Xiong has received numerous recognitions for her contributions to pharmaceutics and nanomedicine. She has been awarded prestigious funding programs, including the National Natural Science Foundation of China Youth Program, the China Postdoctoral Science Foundation, the China Postdoctoral Science Foundation Special Grant, and the Jiangsu Provincial Postdoctoral Research Grant. These awards highlight her scientific achievements and the national recognition of her research potential. In addition to grant support, her publications have earned attention in high-impact journals, with one study featured on the front cover of Advanced Healthcare Materials. Her H-index and total journal impact factor exceeding reflect her influence in the scientific community. Holding four national patents further emphasizes her contribution to pharmaceutical innovation. These honors collectively demonstrate her success in both academic research and translational innovation, positioning her as an influential figure in the field of pharmaceutics-driven cancer nanomedicine.

Publication Top Notes

Engineering Magnesium Oxide as a Mitochondrial Electron Transport Chain Inhibitor for Enhanced Photodynamic Therapy in Triple-Negative Breast Cancer

Year: 2025

Mitochondria-Targeted Ferroptosis Nanodrug for Triple-Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition

Year: 2025

Nanocoated bacteria with H2S generation-triggered self-amplified photothermal and photodynamic effect for breast cancer therapy

Year: 2025
Citation: 2

Conclusion

Dr. Hui Xiong’s impressive research experience, publication record, innovative research, and significant funding make her a strong candidate for the Best Researcher Award. With some additional interdisciplinary collaboration, global impact, and translational research, she could further solidify her position as a leading researcher in her field.

Deborah Lee | Bio Materials | Best Researcher Award

Dr. Deborah Lee | Bio Materials | Best Researcher Award

Assistant Professor | University of Michigan | United States

This individual is an accomplished Critical Care Nurse Practitioner, educator, and healthcare leader with nearly three decades of experience in critical care nursing, emergency medicine, rapid response, and advanced practice. Beginning their career in the coronary care unit, they advanced through supervisory and clinical management roles before transitioning to advanced practice in critical care. Their expertise spans patient management in high-acuity settings, invasive procedures, palliative care, and simulation-based education. At the University of Michigan, they serve as Clinical Assistant Professor and Director of the Clinical Learning Center, where they advance pedagogy in simulation and prepare future nurse practitioners. They also practice as a Critical Care Nurse Practitioner at Henry Ford Health System. Their leadership has influenced rapid response programs, sepsis protocols, simulation training, and interdisciplinary education. With a career blending clinical excellence, innovation, and teaching, they continue to shape both patient outcomes and the next generation of critical care clinicians.

Professional Profile

Scopus

Education

This individual is an accomplished Critical Care Nurse Practitioner, educator, and healthcare leader with nearly three decades of experience in critical care nursing, emergency medicine, rapid response, and advanced practice. Beginning their career in the coronary care unit, they advanced through supervisory and clinical management roles before transitioning to advanced practice in critical care. Their expertise spans patient management in high-acuity settings, invasive procedures, palliative care, and simulation-based education. At the University of Michigan, they serve as Clinical Assistant Professor and Director of the Clinical Learning Center, where they advance pedagogy in simulation and prepare future nurse practitioners. They also practice as a Critical Care Nurse Practitioner at Henry Ford Health System. Their leadership has influenced rapid response programs, sepsis protocols, simulation training, and interdisciplinary education. With a career blending clinical excellence, innovation, and teaching, they continue to shape both patient outcomes and the next generation of critical care clinicians.

Experience

The foundation of this professional’s career is built upon comprehensive education in nursing and advanced practice. After completing initial nursing training and gaining clinical expertise in critical care and emergency nursing, they advanced to graduate-level education as an Adult Gerontology Acute Care Nurse Practitioner (AG-ACNP). Their academic training emphasized pathophysiology, pharmacology, critical care management, and advanced procedures such as intubation and central line insertion. In addition to clinical preparation, their education included curriculum design, clinical instruction, and simulation pedagogy, which later informed their faculty role at the University of Michigan School of Nursing. Their advanced academic preparation has allowed them to function across multiple domains—direct patient care, clinical leadership, palliative care consultation, and academic teaching. Their commitment to lifelong learning is demonstrated by continuous certification in life support programs such as ACLS, PALS, and BLS, and by staying engaged in evidence-based practice, ensuring their knowledge translates to both patient care and student learning.

Research Focus

This professional’s research interests center on critical care nursing, rapid response systems, and simulation-based education. In clinical research, they have focused on the optimization of rapid response protocols, sepsis recognition tools, and early-warning vital sign systems to reduce in-hospital cardiac arrests and improve survival outcomes. Their work also explores palliative care integration into critical care, emphasizing quality of life, symptom management, and transitions to hospice or rehabilitation. In nursing education, they are committed to advancing simulation pedagogy, including psychological safety, scenario development, and the integration of simulation across graduate nursing curricula. As Director of the Clinical Learning Center, they lead initiatives to evaluate the impact of simulation training on clinical readiness, interprofessional teamwork, and patient outcomes. Their scholarship bridges practice and education, reflecting a dual focus on improving both bedside care and the preparation of future advanced practice nurses for complex, high-acuity healthcare environments.

Awards and Honors

Healthcare experience, this professional has held diverse roles spanning clinical, administrative, and academic settings. They began in the coronary care and emergency departments at Hillsdale Community Health Center, advancing to supervisory and clinical management roles. From onward, they served in high-acuity environments at Bronson Methodist Hospital, including the Rapid Response Team, later directing the multidisciplinary rapid response program at Borgess Medical Center. Their advanced practice career includes critical care nurse practitioner roles at Borgess Medical Center, University of Michigan Health System, and most recently, Henry Ford Health System. Alongside clinical practice, they have built an academic career at the University of Michigan School of Nursing, first as Clinical Instructor and later as Clinical Assistant Professor, where they teach and mentor advanced practice nursing students. As Director of the Clinical Learning Center, they oversee simulation pedagogy, faculty development, and accreditation, bridging practice and education seamlessly.

Publication Top Notes

Conclusion

The researcher demonstrates a strong clinical, leadership, teaching, and administrative profile, with a focus on critical care and nurse practitioner education. Their expertise in patient care, leadership, and education make them a strong candidate for the Best Researcher Award. With further research publications, research funding, and interdisciplinary collaboration, they could become an even stronger candidate for this award. Their contributions to the field of nursing and healthcare, and their potential for future research, make them a strong contender for this award.

Assoc. Prof. Dr. Joanna Mystkowska | Biomaterials | Best Researcher Award

Assoc. Prof. Dr. Joanna Mystkowska | Biomaterials | Best Researcher Award

Institute of Biomedical Engineering, Bialystok University of Technology, Poland

The researcher is a distinguished academic and scientist with extensive experience in materials engineering and biomaterials. Currently serving as the Head of the Department of Biomaterials and Medical Devices Engineering at Bialystok University of Technology, they have a strong background in research and education.

Profile

orcid

🎓 Education

– (link unavailable) Degree: Materials Engineering, Warsaw University of Technology (2019)- *Doctor of Technical Sciences*: Materials Engineering, specialty: Biomaterials, Warsaw University of Technology (2008)- *Master of Science*: Enterprise Management, Warsaw University of Technology (2004)- *Master of Science*: Plastics Technology, Warsaw University of Technology (2003)

👨‍🔬 Experience

– *Head of Department*: Biomaterials and Medical Devices Engineering, Bialystok University of Technology (2024-present)- *Associate Professor*: Institute of Biomedical Engineering, Bialystok University of Technology (2019-present)- *Adjunct Lecturer*: Department of Materials Engineering and Production, Bialystok University of Technology (2010-2016)- *Scientific and Teaching Assistant*: Department of Materials and Biomedical Engineering, Bialystok University of Technology (2003-2009)

🔍 Research Interest

– *Polymers and Composites*: Medical applications, degradation processes, and thermal properties- *Biological Fluids*: Modification, physicochemical, biological, rheological, and tribological properties- *Biofilm Investigations*: Surfaces of implant materials

Awards and Honors

– *Academic Award*: Most active employee in Biomedical Engineering discipline (2022)- *Academic Scholarship*: Outstanding young scientists (2014-2017)- *Scholarship*: Young doctors of the Bialystok University of Technology (2010-2011)- *Best Poster Award*: International Conference of the Polish Society of Biomechanics (2012)- *Medal of the National Education Commission* (2012)

📚 Publications 

– Rheological Investigation of Polydimethylsiloxane with Glass Beads: A Model for Compression-Stiffening Effects in Soft Tissue Engineering Materials 🔬
– Influence of Perfluorodecalin Content on the Properties of Blood Substitute 💉
– Mechanical Properties of Inflamed Appendix Tissues 🏥
– Spin-Coating Fabrication Method of PDMS/NdFeB Composites Using Chitosan/PCL Coating 🎨
– Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells 🎯
– Degradation of Polylactide and Polycaprolactone as a Result of Biofilm Formation 🌿
– N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms 💡

Conclusion

The researcher’s impressive academic background, leadership roles, international experience, and awards make them an excellent candidate for the Best Researcher Award. Their research focus on polymers and composites for medical applications, degradation processes, and biological fluids demonstrates their expertise and potential to make significant contributions to their field. With some potential for interdisciplinary collaborations and industry partnerships, the researcher is well-suited to receive this award.